Pancreatic Cancer Research

ResearcherZhengzhou UniversityNo recent work listed

Xiuling Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1175-2622; OpenAlex author ID A5100763045. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers

Papers 3

  1. Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231. Co-author DOI 10.2147/ott.s259598↗
  2. Erratum: Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells [Corrigendum]. Co-author DOI 10.2147/ott.s259765↗
  3. LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.jphs.2018.06.002↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bowei Liu · 2 shared papers, 2020 · strength 0.24
  2. Shuangyin Han · 2 shared papers, 2020 · strength 0.24
  3. Zhaoshen Li · 1 shared paper, 2020 · strength 0.12
  4. Wei Ting Wang · 1 shared paper, 2020 · strength 0.12
  5. Fan Yang · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.